Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Technology
1.1.3 Application
1.1.4 Test Location
1.1.5 Regional Scope
1.1.6 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights
Chapter 3 Infectious Diseases In Vitro Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.3.3 List of key end users
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Growing geriatric population
3.5.1.2 Technological advancements
3.5.1.3 High demand for PoC facilities
3.5.1.4 Increasing prevalence of infectious diseases
3.5.1.5 External funding for R&D activities
3.5.2 Market restraint analysis
3.5.2.1 High prices of IVD tests
3.5.3 Industry challenges
3.5.3.1 Presence of ambiguous regulatory framework
3.6 Infectious Diseases In Vitro Diagnostics Market Analysis Tools
3.6.1 Industry analysis - Porter’s
3.6.2 PESTLE Analysis
3.6.3 Major deals and strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.4 Market entry strategies
Chapter 4 Infectious Diseases In Vitro Diagnostics Market - Segment Analysis, By Product, 2017 - 2028 (USD Million)
4.1 Definition and Scope
4.2 Product Type Market Share Analysis, 2020 & 2028
4.3 Segment Dashboard
4.4 Global Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 to 2028
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2017 - 2028 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 5 Infectious Diseases In Vitro Diagnostics Market - Segment Analysis, By Technology, 2017 - 2028 (USD Million)
5.1 Definition and Scope
5.2 Technology Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Infectious Diseases In Vitro Diagnostics Market, by Technology, 2017 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.5.1 Immunoassay
5.5.1.1 Immunoassay market estimates and forecast, 2017 - 2028 (USD Million)
5.5.2 Molecular diagnostics
5.5.2.1 Molecular diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
5.5.3 Microbiology
5.5.3.1 Microbiology market estimates and forecast, 2017 - 2028 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 Infectious Diseases In Vitro Diagnostics Market - Segment Analysis, By Application, 2017 - 2028 (USD Million)
6.1 Definition and Scope
6.2 Application Type Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Infectious Diseases In Vitro Diagnostics Market, by Application, 2017 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 MRSA
6.5.1.1 MRSA market estimates and forecast, 2017 - 2028 (USD Million)
6.5.2 Streptococcus
6.5.2.1 Streptococcus market estimates and forecast, 2017 - 2028 (USD Million)
6.5.3 Clostridium difficile
6.5.3.1 Clostridium difficile market estimates and forecast, 2017 - 2028 (USD Million)
6.5.4 Vancomycin-resistant enterococci (VRE)
6.5.4.1 VRE market estimates and forecast, 2017 - 2028 (USD Million)
6.5.5 Carbapenem-resistant enterobacterial testing (CRE)
6.5.5.1 CRE market estimates and forecast, 2017 - 2028 (USD Million)
6.5.6 Respiratory virus
6.5.6.1 Respiratory virus market estimates and forecast, 2017 - 2028 (USD Million)
6.5.7 Candida
6.5.7.1 Candida market estimates and forecast, 2017 - 2028 (USD Million)
6.5.8 Tuberculosis (TB) & drug-resistant TB
6.5.8.1 TB & drug-resistant TB market estimates and forecast, 2017 - 2028 (USD Million)
6.5.9 Gastrointestinal (GI) panel testing
6.5.9.1 GI panel testing market estimates and forecast, 2017 - 2028 (USD Million)
6.5.10 Chlamydia
6.5.10.1 Chlamydia market estimates and forecast, 2017 - 2028 (USD Million)
6.5.11 Gonorrhea
6.5.11.1 Gonorrhea market estimates and forecast, 2017 - 2028 (USD Million)
6.5.12 Human Papillomavirus (HPV)
6.5.12.1 HPV market estimates and forecast, 2017 - 2028 (USD Million)
6.5.13 Human Immunodeficiency Virus (HIV)
6.5.13.1 HIV market estimates and forecast, 2017 - 2028 (USD Million)
6.5.14 Hepatitis C
6.5.14.1 Hepatitis C market estimates and forecast, 2017 - 2028 (USD Million)
6.5.15 Hepatitis B
6.5.15.1 Hepatitis B market estimates and forecast, 2017 - 2028 (USD Million)
6.5.16 COVID-19
6.5.16.1 COVID-19 market estimates and forecast, 2017 - 2028 (USD Million)
6.5.17 Others
6.5.17.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 7 Infectious Diseases In Vitro Diagnostics Market - Segment Analysis, By End Use, 2017 - 2028 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2020 & 2028
7.3 Segment Dashboard
7.4 Global Infectious Diseases In Vitro Diagnostics Market, by end use, 2017 to 2028
7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
7.5.1 Point of care
7.5.1.1 Point of care market estimates and forecast, 2017 - 2028 (USD Million)
7.5.2 Central laboratories
7.5.2.1 Central laboratories market estimates and forecast, 2017 - 2028 (USD Million)
7.5.3 Others
7.5.3.1 Others market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 8 Infectious Diseases In Vitro Diagnostics Market - Segment Analysis, By Region, 2017 - 2028 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2020 & 2028
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 Regional Market Share and Leading Players, 2020
8.5.1 North america
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 SWOT Analysis
8.6.1 North America
8.6.2 Europe
8.6.3 Asia Pacific
8.6.4 Latin America
8.6.5 Middle East and Africa
8.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
8.7.1 North America
8.7.1.1 North America market estimates and forecast, 2017-2028 (USD Million)
8.7.1.2 U.S.
8.7.1.2.1 U.S. infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.1.3 Canada
8.7.1.3.1 Canada Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.2 Europe
8.7.2.1 Europe market estimates and forecast, 2017-2028 (USD Million)
8.7.2.2 U.K.
8.7.2.2.1 U.K. Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.2.3 Germany
8.7.2.3.1 Germany Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.2.4 Spain
8.7.2.4.1 Spain Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.2.5 France
8.7.2.5.1 France Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.2.6 Italy
8.7.2.6.1 Italy Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.3 Asia Pacific
8.7.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.3.2 Japan
8.7.3.2.1 Japan Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.3.3 China
8.7.3.3.1 China Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.3.4 India
8.7.3.4.1 India Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.3.5 South Korea
8.7.3.5.1 South Korea Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.3.6 Australia
8.7.3.6.1 Australia Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.4 Latin America
8.7.4.1 Latin America market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.4.2 Brazil
8.7.4.2.1 Brazil Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.4.3 Mexico
8.7.4.3.1 Mexico Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.4.4 Argentina
8.7.4.4.1 Argentina Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.5 MEA
8.7.5.1 MEA market estimates and forecast estimates and forecast, 2017-2028 (USD Million)
8.7.5.2 South Africa
8.7.5.2.1 South Africa Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.5.3 Saudi Arabia
8.7.5.3.1 Saudi Arabia Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
8.7.5.4 UAE
8.7.5.4.1 UAE Infectious diseases in vitro diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 9 COMPETITIVE LANDSCAPE
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.3.3 Key company market share analysis, 2020
9.4 Public Companies
9.4.1 Company market position analysis
9.4.2 Company Market Share, by region, 2020
9.4.3 Competitive Dashboard Analysis
9.4.3.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 Becton, Dickinson and Company
9.6.1.1 Company Overview
9.6.1.2 Financial Performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic initiatives
9.6.2 bioM?rieux SA
9.6.2.1 Company overview
9.6.2.2 Financial Performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Abbott
9.6.3.1 Company Overview
9.6.3.2 Financial Performance
9.6.3.3 Product Benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Quidel Corporation
9.6.4.1 Company Overview
9.6.4.2 Financial Performance
9.6.4.3 Product Benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 OraSure Technologies, Inc
9.6.5.1 Company Overview
9.6.5.2 Financial Performance
9.6.5.3 Product Benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Hologic Inc. (Gen Probe)
9.6.6.1 Company Overview
9.6.6.2 Financial Performance
9.6.6.3 Product Benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Cepheid (Danaher)
9.6.7.1 Company Overview
9.6.7.2 Financial Performance
9.6.7.3 Product Benchmarking
9.6.7.4 Strategic Initiatives
9.6.8 Qiagen
9.6.8.1 Company Overview
9.6.8.2 Financial Performance
9.6.8.3 Product Benchmarking
9.6.8.4 Strategic Initiatives
9.6.9 F. Hoffmann-La Roche Ltd.
9.6.9.1 Company Overview
9.6.9.2 Financial Performance
9.6.9.3 Product Benchmarking
9.6.9.4 Strategic Initiatives
9.6.10 Siemens Healthcare GmbH
9.6.10.1 Company Overview
9.6.10.2 Financial Performance
9.6.10.3 Product Benchmarking
9.6.10.4 Strategic Initiatives
9.6.11 Bio-Rad Laboratories, Inc.
9.6.11.1 Company Overview
9.6.11.2 Financial Performance
9.6.11.3 Product Benchmarking
9.6.11.4 Strategic Initiatives



List of Tables



TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Infectious Diseases In Vitro Diagnostics Market, By Region, 2017 - 2028 (USD Million)
TABLE 5 Global Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 6 Global Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 7 Global Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 8 Global Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 9 North America Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 10 North America Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 11 North America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 12 North America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 13 North America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 14 U.S. Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 15 U.S. Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 16 U.S. Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 17 U.S. Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 18 Canada Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 19 Canada Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 20 Canada Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 21 Canada Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 22 Europe Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 23 Europe Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 24 Europe Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 25 Europe Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 26 Europe Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 27 U.K. Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 28 U.K. Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 29 U.K. Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 30 U.K. Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 31 Germany Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 32 Germany America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 33 Germany America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 34 Germany America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 35 France Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 36 France Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 37 France Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 38 France Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 39 Spain Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 40 Spain Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 41 Spain Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 42 Spain Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 43 Italy Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 44 Italy Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 45 Italy Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 46 Italy Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 47 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 48 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 49 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 50 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 51 Asia Pacific Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 52 China Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 53 China Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 54 China Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 55 China Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 56 Japan Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 57 Japan Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 58 Japan Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 59 Japan Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 60 India Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 61 India Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 62 India Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 63 India Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 64 South Korea Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 65 South Korea Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 66 South Korea Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 67 South Korea Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 68 Australia Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 69 Australia Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 70 Australia Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 71 Australia Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 72 Latin America Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 73 Latin America Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 74 Latin America Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 75 Latin America Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 76 Latin America Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 77 Brazil Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 78 Brazil Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 79 Brazil Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 80 Brazil Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 81 Mexico Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 82 Mexico Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 83 Mexico Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 84 Mexico Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 85 Argentina Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 86 Argentina Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 87 Argentina Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 88 Argentina Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 89 MEA Infectious Diseases In Vitro Diagnostics Market, By Country, 2017 - 2028 (USD Million)
TABLE 90 MEA Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 91 MEA Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 92 MEA Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 93 MEA Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 94 South Africa Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 95 South Africa Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 96 South Africa Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 97 South Africa Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 98 UAE Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 99 UAE Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 100 UAE Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 101 UAE Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)
TABLE 102 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Product, 2017 - 2028 (USD Million)
TABLE 103 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Technology, 2017 - 2028 (USD Million)
TABLE 104 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By Application, 2017 - 2028 (USD Million)
TABLE 105 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market, By End Use, 2017 - 2028 (USD Million)